Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Monk

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Journal of the National Cancer Institute|October 2, 1996
Human papillomavirus type 18: association with poor prognosis in early stage cervical cancerR A Burger, B J Monk, T Kurosaki, et al.
Gynecologic Oncology|November 25, 1998
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancersB J Monk, D S Alberts, R A Burger, et al.
Gynecologic Oncology|February 18, 1999
Protein kinase C isoform expression and activity alter paclitaxel resistance in vitroL Chen, R A Burger, G M Zaunbrecher, et al.
Gynecologic Oncology|July 2, 1998
Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical stagingP Y Kim, B J Monk, S Chabra, et al.
Gynecologic Oncology|July 1, 1994
Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinomaB J Monk, D S Cha, J L Walker, et al.
Gynecologic Oncology|March 31, 2000
Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft modelK S Tewari, J A Taylor, S Y Liao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 10, 2006
Human immunodeficiency virus testing in patients with invasive cervical carcinoma: a prospective trial of the gynecologic oncology groupA Calkins, F B Stehman, B Bundy, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2001
Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancerJ B Welsh, P P Zarrinkar, L M Sapinoso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervixW A Peters, P Y Liu, R J Barrett, et al.
Cancer|March 10, 2001
Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapyK S Tewari, F Cappuccini, A A Puthawala, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Journal of the National Cancer Institute|October 2, 1996
Human papillomavirus type 18: association with poor prognosis in early stage cervical cancerR A Burger, B J Monk, T Kurosaki, et al.
Gynecologic Oncology|November 25, 1998
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancersB J Monk, D S Alberts, R A Burger, et al.
Gynecologic Oncology|February 18, 1999
Protein kinase C isoform expression and activity alter paclitaxel resistance in vitroL Chen, R A Burger, G M Zaunbrecher, et al.
Gynecologic Oncology|July 2, 1998
Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical stagingP Y Kim, B J Monk, S Chabra, et al.
Gynecologic Oncology|July 1, 1994
Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinomaB J Monk, D S Cha, J L Walker, et al.
Gynecologic Oncology|March 31, 2000
Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft modelK S Tewari, J A Taylor, S Y Liao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 10, 2006
Human immunodeficiency virus testing in patients with invasive cervical carcinoma: a prospective trial of the gynecologic oncology groupA Calkins, F B Stehman, B Bundy, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2001
Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancerJ B Welsh, P P Zarrinkar, L M Sapinoso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervixW A Peters, P Y Liu, R J Barrett, et al.
Cancer|March 10, 2001
Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapyK S Tewari, F Cappuccini, A A Puthawala, et al.
Pageof 7